Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Apr 5

PMID 27043143

Citations 141

Authors

Somaiya Mateen

Shagufta Moin

Abdul Qayyum Khan

Atif Zafar

Naureen Fatima

Affiliations

Soon will be listed here.

Abstract

Background: Rheumatoid arthritis (RA) is an autoimmune inflammatory disorder. Highly reactive oxygen free radicals are believed to be involved in the pathogenesis of the disease. In this study, RA patients were sub-grouped depending upon the presence or absence of rheumatoid factor, disease activity score and disease duration. RA Patients (120) and healthy controls (53) were evaluated for the oxidant-antioxidant status by monitoring ROS production, biomarkers of lipid peroxidation, protein oxidation and DNA damage. The level of various enzymatic and non-enzymatic antioxidants was also monitored. Correlation analysis was also performed for analysing the association between ROS and various other parameters.

Methods: Intracellular ROS formation, lipid peroxidation (MDA level), protein oxidation (carbonyl level and thiol level) and DNA damage were detected in the blood of RA patients. Antioxidant status was evaluated by FRAP assay, DPPH reduction assay and enzymatic (SOD, catalase, GST, GR) and non-enzymatic (vitamin C and GSH) antioxidants.

Results: RA patients showed a higher ROS production, increased lipid peroxidation, protein oxidation and DNA damage. A significant decline in the ferric reducing ability, DPPH radical quenching ability and the levels of antioxidants has also been observed. Significant correlation has been found between ROS and various other parameters studied.

Conclusion: RA patients showed a marked increase in ROS formation, lipid peroxidation, protein oxidation, DNA damage and decrease in the activity of antioxidant defence system leading to oxidative stress which may contribute to tissue damage and hence to the chronicity of the disease.

Citing Articles

Programmed Cell Death in Rheumatoid Arthritis.

Tong L, Qiu J, Xu Y, Lian S, Xu Y, Wu X J Inflamm Res. 2025; 18:2377-2393.

PMID: 39991656 PMC: 11846511. DOI: 10.2147/JIR.S499345.

Metabolic reprogramming and macrophage expansion define ACPA-negative rheumatoid arthritis: insights from single-cell RNA sequencing.

Jiang Y, Hu Z, Huang R, Ho K, Wang P, Kang J Front Immunol. 2025; 15():1512483.

PMID: 39830504 PMC: 11739280. DOI: 10.3389/fimmu.2024.1512483.

Evaluation of serum total antioxidant level, nutritional status and Mediterranean diet adherence of adult women with rheumatoid arthritis: a case-control study.

Bekar C, Armagan B, Sari A, Ayaz A Br J Nutr. 2025; 133(2):239-245.

PMID: 39758032 PMC: 11813622. DOI: 10.1017/S0007114524003386.

Association between plasma trans fatty acid levels and rheumatoid arthritis: a cross-sectional study using NHANES 1999-2000 and 2009-2010 data in US adults.

Li T, Jiang N, Liang X, Li X, Li Y, Huang Y Front Nutr. 2024; 11:1413091.

PMID: 39726872 PMC: 11670744. DOI: 10.3389/fnut.2024.1413091.

The role of vitamins D, B12, C, and K in modulating inflammation and disease management in rheumatoid arthritis: a comprehensive review.

Hijjawi N, Tout F, Azaizeh B, Aljaafreh B Clin Rheumatol. 2024; 44(2):591-600.

PMID: 39722107 DOI: 10.1007/s10067-024-07285-9.

References

Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R . Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003; 329(1-2):23-38. DOI: 10.1016/s0009-8981(03)00003-2. View

Jaswal S, Mehta H, Sood A, Kaur J . Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta. 2003; 338(1-2):123-9. DOI: 10.1016/j.cccn.2003.08.011. View

Reznick A, Packer L . Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 1994; 233:357-63. DOI: 10.1016/s0076-6879(94)33041-7. View

Cooke M, Olinski R, Evans M . Does measurement of oxidative damage to DNA have clinical significance?. Clin Chim Acta. 2005; 365(1-2):30-49. DOI: 10.1016/j.cca.2005.09.009. View

Seven A, Guzel S, Aslan M, Hamuryudan V . Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clin Biochem. 2008; 41(7-8):538-43. DOI: 10.1016/j.clinbiochem.2008.01.029. View

Kamanli A, Naziroglu M, Aydilek N, Hacievliyagil C . Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct. 2003; 22(1):53-7. DOI: 10.1002/cbf.1055. View

Biemond P, Swaak A, Koster J . Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid. Arthritis Rheum. 1984; 27(7):760-5. DOI: 10.1002/art.1780270706. View

Sarban S, Kocyigit A, Yazar M, Isikan U . Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem. 2005; 38(11):981-6. DOI: 10.1016/j.clinbiochem.2005.08.003. View

Maki-Petaja K, Cheriyan J, Booth A, Hall F, Brown J, Wallace S . Inducible nitric oxide synthase activity is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunction. Int J Cardiol. 2008; 129(3):399-405. DOI: 10.1016/j.ijcard.2008.02.011. View

10.

Mulherin D, Thurnham D, Situnayake R . Glutathione reductase activity, riboflavin status, and disease activity in rheumatoid arthritis. Ann Rheum Dis. 1996; 55(11):837-40. PMC: 1010321. DOI: 10.1136/ard.55.11.837. View

11.

Ozturk H, Cimen M, Cimen O, Kacmaz M, Durak I . Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int. 2000; 19(1-2):35-7. DOI: 10.1007/s002960050097. View

12.

Sedlak J, Lindsay R . Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968; 25(1):192-205. DOI: 10.1016/0003-2697(68)90092-4. View

13.

Keller A, Mohamed A, Drose S, Brandt U, Fleming I, Brandes R . Analysis of dichlorodihydrofluorescein and dihydrocalcein as probes for the detection of intracellular reactive oxygen species. Free Radic Res. 2005; 38(12):1257-67. DOI: 10.1080/10715760400022145. View

14.

Altindag O, Karakoc M, Kocyigit A, Celik H, Soran N . Increased DNA damage and oxidative stress in patients with rheumatoid arthritis. Clin Biochem. 2007; 40(3-4):167-71. DOI: 10.1016/j.clinbiochem.2006.10.006. View

15.

Ali A, Habeeb R, El-Azizi N, Khattab D, Abo-Shady R, Elkabarity R . [Higher nitric oxide levels are associated with disease activity in Egyptian rheumatoid arthritis patients]. Rev Bras Reumatol. 2014; 54(6):446-51. DOI: 10.1016/j.rbr.2014.07.003. View

16.

Krane S, Simon L . Rheumatoid arthritis: clinical features and pathogenetic mechanisms. Med Clin North Am. 1986; 70(2):263-84. DOI: 10.1016/s0025-7125(16)30953-1. View

17.

AEBI H . Catalase in vitro. Methods Enzymol. 1984; 105:121-6. DOI: 10.1016/s0076-6879(84)05016-3. View

18.

JOLLOW D, Mitchell J, Zampaglione N, GILLETTE J . Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 1974; 11(3):151-69. DOI: 10.1159/000136485. View

19.

van der Linden M, Knevel R, Huizinga T, van der Helm-van Mil A . Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria. Arthritis Rheum. 2010; 63(1):37-42. DOI: 10.1002/art.30100. View

20.

Janaszewska A, Bartosz G . Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma. Scand J Clin Lab Invest. 2002; 62(3):231-6. DOI: 10.1080/003655102317475498. View